Skip to main content

Myriad Genetics Inc

MYGN
Exchange
Nasdaq
Industry
In Vitro & In Vivo Diagnostic Substances
SEC CIK
0000899923

No open-market purchases or sales by Myriad Genetics Inc insiders were filed in the last 90 days; 196 institutions reported holding it in 13F filings for Q2 2026, worth $507.8M in total; no superinvestor holds it.

Q2 2023 vs. Q1 2023

How the institutions holding Myriad Genetics Inc changed between Q1 2023 and Q2 2023.

All holders in Q2 2023All holders in Q1 2023

13F holders of MYGN: Q1 2023 compared with Q2 2023
MeasureQ1 2023Q2 2023Change
Holders190188−2
Shares82.2M81.2M−1.08M (−1.3%)
Value$1.91B$1.88B−$31.1M (−1.6%)

New holders (21)

Institutions that held Myriad Genetics Inc at the end of Q2 2023 but not at the end of Q1 2023.

Institutions new to MYGN in Q2 2023
InstitutionSharesValue% of portfolio
ExodusPoint Capital Management, LP361,617$8.38M0.10%
Peregrine Capital Management LLC298,389$6.92M0.19%
AMH Equity Ltd110,000$2.55M2.91%
Caption Management, LLC85,017$1.97M0.35%
Jump Financial, LLC73,218$1.70M0.06%
Franklin Resources Inc42,247$979.3K0.00%
Edgestream Partners, L.P.30,092$697.5K0.06%
Qube Research & Technologies Ltd18,553$430.1K0.00%
Ensign Peak Advisors, Inc16,350$379.0K0.00%
Engineers Gate Manager LP13,941$323.2K0.01%
Vontobel Holding Ltd.11,660$270.3K0.00%
Cresset Asset Management, LLC10,848$251.5K0.00%
XTX Topco Ltd9,825$227.7K0.04%
Teza Capital Management LLC9,766$226.4K0.04%
Graham Capital Management, L.P.8,815$204.3K0.01%
Byrne Asset Management LLC500$12.0K0.01%
Bessemer Group Inc68$2.00K0.00%
Cullen/Frost Bankers, Inc.74$1.72K0.00%
Point72 Asset Management, L.P.35$8160.00%
Abound Wealth Management11$2550.00%
Comerica Bank96,838$30.00%

Sold out (23)

Institutions that held Myriad Genetics Inc at the end of Q1 2023 and filed for Q2 2023 without it.